The landscape at PUF Ventures is experiencing a major change to our future direction. Over the next several weeks, we will be unveiling a new name, brand and website as we create the fertile ground from which PUF will grow for the many years to come.
Today’s exciting announcement regarding Health Canada’s granting AAA Heidelberg a medical cannabis cultivation license demonstrates our commitment to becoming a leading company in the emerging cannabis marketplace in Canada and around the world. While it has been a challenge navigating the changing regulatory environment as we pursued our license to produce medical cannabis, our patience has paid off and we are now in the position to quickly move the Company forward to the benefit of PUF shareholders.
Over the past 18 months we have focused our strategy to diversify and mitigate risk in response to the ever-changing cannabis sector. With the legalization of cannabis in Canada occurring on October 17, 2018, we are witnessing the birth of an entire new industry. Pioneers and early adopters like PUF will not only become the leaders of this new multi-billion-dollar industry, but they will also establish how the industry will work for future generations. We are now officially part of that conversation.
We have laid out a roadmap which allows PUF to succeed in the current and future landscape of the global cannabis industry; we have taken steps to expand our operations on a domestic and international basis; we have created ancillary businesses which provides our Company value today and in the future. Much work has been done and there is much more work to do.
Our new brand will better reflect the diversified nature of our business and the multiple holdings that make PUF great. More news to come.
Below you will find links to the dynamic collection of PUF related companies.
President & CEO
PUF VENTURES INC.
AAA Heidelberg is an advanced Access to Cannabis for Medical Purposes Regulations (“ACMPR”) licensed cultivator with a facility in London, ON.
Cannvas MedTech (CSE: MTEC) is a leading business technology company within the cannabis health sciences space.
The Company designs and builds customer-centric solutions that enable our partners to harness the power of data to truly understand their customers, industry, and key business drivers.
PUF Ventures and the Houweling’s Group have joined forces to create one of the largest cannabis propagation companies in the world.
With an existing 2.2 million sq. ft. propagation greenhouse located in Delta, BC, PSC will offer propagation services to licensed producers looking to outsource the complex process of replicating pure, disease and contaminate free, high quality clones, resulting in improved top line revenue and operating profits.
Solaris Nutraceuticals is an innovative medical technology company headquartered in Sydney, Australia.
Solaris has submitted applications and plans with Australia’s Office of Drug Control to build a 1.2 million square-foot greenhouse facility with cannabis production space and a medical research center in the Northern Rivers Region of New South Wales, Australia.
Nature Hemp is a biotechnology and consumer products company focused on unlocking the true value of hemp and developing a new generation of plant-based, nutrient rich cannabidiol (CBD) food, beverage and healthcare related products.
The Company is establishing its own farms to produce high quality organic hemp plants and using a proprietary extraction technology to produce legal hemp fibers and CBD extract. Natures Hemp is launching a premium brand of quality CBD products with an emphasis on health and wellness.
VANCOUVER, Nov. 16, 2017 /CNW/ – PUF Ventures Inc. (“PUF” or the “Company”) (CSE: PUF) (Frankfurt: PU3) (OTCPK: PUFXF), an advanced Access to Cannabis for Medical Purposes Regulations (“ACMPR”) license applicant, is pleased to announce that PUF Ventures Australia (“PUFA”) has retained Mr. Casey Houwelings and Mr. Peter Cummings as greenhouse consultants for the medical cannabis Northern River Project, a 1,200,000-square foot greenhouse being constructed in north eastern New South Wales. Houwelings and Cummings will contribute to the design and construction of the most technically advanced and environmentally sustainable greenhouse to grow medical cannabis.
news about the industry and investment oportunities.